Asia Pacific Point Of Care Diagnostics Market To Reach $15.61 Billion By 2030

October 2023 | Report Format: Electronic (PDF)

Asia Pacific Point Of Care Diagnostics Market Growth & Trends

The Asia Pacific point of care diagnostics market is expected to reach USD 15.61 billion by 2030, registering a CAGR of 8.1%, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with a rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of point of care (PoC) products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expected to be key market factors.

The rapidly growing use of point of care diagnostic products has introduced a decentralization trend in the overall healthcare industry. Healthcare facilities and patients, in an attempt to attain or cater medical facilities remotely, encourage early diagnosis and curb costs are now decentralizing their facilities. Furthermore, these trends have also triggered the establishment of remote and stand-alone diagnostic facilities.


key Request a free sample copy or view report summary: Asia Pacific Point Of Care Diagnostics Market Report


Asia Pacific Point Of Care Diagnostics Market Report Highlights

  • The infectious diseases segment dominated the market with the highest revenue share in 2022 owing to the increasing adoption of point of care diagnostics as a substitute for traditional laboratory testing in infectious diseases applications.

  • The cancer markers segment is expected to grow at the fastest CAGR over the forecast period from 2023 to 2030. The Asia Pacific region has experienced a notable rise in the prevalence of cancer in recent years.

  • The clinics segment held the largest revenue share of over 35% in 2022. Clinics are essential in providing healthcare services, particularly in remote and underserved areas.

  • China dominated the Asia Pacific PoC diagnostics market with a revenue share of over 40% in 2022. China has the world's largest population and faces notable challenges related to the prevalence of chronic and infectious diseases within its borders resulting in an increasing demand for point-of-care diagnostics.

Asia Pacific Point Of Care Diagnostics Market Segmentation

Grand View Research has segmented the Asia Pacific point of care diagnostics market report on the basis of product, end-use, and region:

Asia Pacific Point Of Care Diagnostics Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Glucose Testing

  • Hb1Ac Testing

  • Coagulation

  • Fertility/Pregnancy

  • Infectious Disease

    • HIV POC

    • Clostridium Difficile POC

    • HBV POC

    • Pneumonia or Streptococcus Associated Infections

    • Respiratory Syncytial Virus (RSV) POC

    • HPV POC

    • Influenza/Flu POC

    • HCV POC

    • MRSA POC

    • TB and Drug-resistant TB POC

    • HSV POC

    • COVID-19

    • Other Infectious Diseases

  • Cardiac Markers

  • Thyroid Stimulating Hormone

  • Hematology

  • Primary Care Systems

  • Decentralized Clinical Chemistry

  • Feces

  • Lipid Testing

  • Cancer Marker

  • Blood Gas/Electrolytes

  • Ambulatory Chemistry

  • Drug Abuse Testing

  • Autoimmune Disease

  • Urinalysis/Nephrology

Asia Pacific Point Of Care Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Clinics

    • Physician Office

    • Pharmacy & Retail Clinics

    • Non-practice Clinics

    • Urgent Care Clinic

  • Hospitals

  • Home

  • Assisted Living Healthcare Facilities

  • Laboratory

Asia Pacific Point Of Care Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

    • New Zealand

    • Singapore

    • Vietnam

List of Key Players in the Asia Pacific Point Of Care Diagnostics Market

  • Wipro

  • ZOE Limited

  • Vocalis Health

  • DarwinAI

  • Biocogniv Inc.

  • Laipac Technology Inc.

  • Gauss Surgical, Inc.

  • Oxford Immune Algorithmics Ltd

  • F. Hoffmann-La Roche Ltd.

  • QIAGEN

  • Danaher

  • Beckman Coulter, Inc.

  • Radiometer Medical ApS

  • HemoCue AB

  • BD (Becton, Dickinson, and Company)

  • BIOMÉRIEUX

  • Abbott

  • Siemens Healthcare GmbH

  • Zoetis Services LLC

  • Abaxis

  • Instrumentation Laboratory Company

  • Nova Biomedical

  • Trividia Health, Inc.

  • Quidel Corporation

  • Trinity Biotech

  • SEKISUI Diagnostics

  • Orasure Technologies, Inc.

  • Nipro Europe Group Companies

  • Spectral Medical Inc.

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.